DEF 14ACRSPCIK 0001674416
CRISPR Therapeutics AG
Proxy statement (DEF 14A) filed .
Definitive proxy statement disclosing matters to be voted on by shareholders, including executive compensation.
Filing facts
- Accession number
- 0000950170-24-043025
- Filer
- CRISPR Therapeutics AG
- Ticker
- CRSP
- CIK
- 0001674416
- Form type
- DEF 14A
- Form description
- Proxy statement
- Filed at
- April 9, 2024
- Period of report
- 2024-05-30
- Industry
- SIC 2836Biological Products
- Filing size
- 6.0 MB
- Last verified
- August 26, 2026SecFilingDex pulls from EDGAR with daily cadence
Provenance
Authoritative source — SEC EDGAR
https://www.sec.gov/Archives/edgar/data/1674416/000095017024043025/0000950170-24-043025-index.htm ↗Filer's full EDGAR submission history
EDGAR · CRISPR Therapeutics AG (0001674416) ↗Machine-readable JSON twin (LLM-citation friendly)
/api/filing/0000950170-24-043025.jsonSecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.